Pfizer and its partner BioNTech has submitted data that says their coronavirus vaccines no longer need ultra-cold storage and can be stored in refrigerators now.
Currently the Pfizer vaccine has to be stored at minus 70 degree Celsius. (Photo: Reuters)
Pfizer and partner BioNTech SE say that their coronavirus vaccines will no longer require ultra-cold storage.
As per a report, Pfizer and partner BioNTech SE said on Friday they have submitted new data to the US health regulator showing the stability of their Covid-19 vaccine at temperatures commonly found in pharmaceutical freezers and refrigerators.
Currently, Pfizer coronavirus vaccine needs to be kept at -70 degrees Celsius which arises various logistical issues particularly in lower-income countries that don’t have the ultra-cold-storage infrastructure.
Pfizer/BioNTech’s current label requires the vaccine to be stored in an ultra-cold freezer at temperatures between -80oC and -60oC (-112oF to -76oF), calling for it to be shipped in specially designed containers.
As per the report, the companies said the new data has been submitted to the US Food and Drug Administration to support a proposed update to the current EUA label, which would allow for vaccine vials to be stored at -25°C to -15°C (-13°F to 5°F) for a total of two weeks as an alternative for storage in an ultra-low temperature freezer.
Pfizer/BioNTech’s vaccine, along with Moderna Inc’s two-dose vaccine, won the US emergency use authorization (EUA) and is being widely distributed as part of the country’s mass vaccination efforts.
Also Read | Donald Trump questions timing of Pfizer vaccine announcement
Also Read | Behind Pfizer’s Covid-19 vaccine, an understated husband-and-wife ‘dream team’
Also Watch | Pfizer, BioNTech claim their Covid-19 vaccine 90 pc effective in Phase 3 trial